Kunming Guiyan Pharmaceutical Co., Ltd. (KGP),is a company focusing on manufacturing and developing Pt-drugs. he main products: bulk drug, Cisplatin, Carboplatin, Oxaliplatin passed the Chinese national GMP authentication and got CEP certificates. The company produces Nedaplatin, Satraplatin, Picoplatin, the critical intermediate of Pt-drugs, The company is also exploring techniques to develop new Pt-drugs and organic antitumor drugs.
more >
Year of Establishment:
2004
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
100-500
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
All,Distributor
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: